Drug Type Polyclonal antibody |
Synonyms A-IFN-gamma, Anti-IFN-γ polyclonal antibody, Anti-interferon-gamma polyclonal antibody + [1] |
Target |
Mechanism IFNγ inhibitors(Interferon gamma inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epidermolysis Bullosa | Phase 2 | US | - | |
Herpes Simplex | Phase 2 | RU | - | |
Keratoplasty rejection | Phase 2 | RU | - | |
Multiple Sclerosis | Phase 2 | RU | - | |
Pemphigus | Phase 2 | RU | - | |
Rheumatoid Arthritis | Phase 2 | RU | - | |
Systemic Lupus Erythematosus | Phase 2 | RU | - | |
Systemic Lupus Erythematosus | Phase 2 | US | - | |
Uveitis | Phase 2 | RU | - | |
Vitiligo | Phase 2 | US | - |